Skip to main content
. 2024 Jun 18;12(6):677. doi: 10.3390/vaccines12060677
HGSOCs High-grade serous ovarian cancers
PDSLCs Poorly differentiated stem-like cells
NK cells Natural killer cells
sNK cells Supercharged NK cells
IFN-γ Interferon-gamma
CAFs Cancer-associated fibroblasts
IL-6 Interleukin 6
LPP Lipoma preferred partner
OCs Osteoclasts
EMT Epithelial–mesenchymal transition
ETBR Endothelin B receptor
TILs Tumor-infiltrating lymphocytes
MHC-class I Major histocompatibility complex molecule class I
ADCC Antibody-dependent cellular cytotoxicity (ADCC)